Produkty 17086-76-9

CAS 17086-76-9 występuje w naszej ofercie pod nazwami: Cyasterone, (3S,4S,5R)-4-((2R,3R)-2,3-Dihydroxy-3-((2S,3R,5R,9R,10R,13R,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)butyl)-5-hydroxy-3-methyltetrahydro-2H-pyran-2-one, ≥98%, ≥98%, Cyasterone, 99.58%, Cyasterone (Standard), Cyasterone 97%. Oferty producentów: GLPBio, TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 10mg, 20mg, 5mg, 1mg, 25mg, 50mg, 100mg, 500mg.

Cyasterone
GLPBio, TargetMol, Biosynth
  • opakowanie: 10mg, 20mg, 5mg, 1mg
  • Warianty: 16
od 386,15
Zobacz produkt
(3S,4S,5R)-4-((2R,3R)-2,3-Dihydroxy-3-((2S,3R,5R,9R,10R,13R,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)butyl)-5-hydroxy-3-methyltetrahydro-2H-pyran-2-one, ≥98%, ≥98%
Chemat
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 285,20
Zobacz produkt
Cyasterone, 99.58%
MedChemExpress
  • opakowanie: 5 mg, 10 mg, 20 mg, 10mM/1mL
  • Warianty: 4
od 505,45
Zobacz produkt
Cyasterone (Standard)
MedChemExpress
  • opakowanie: 5 mg, 50 mg, 25 mg, 100 mg
  • Warianty: 6
od 649,42
Zobacz produkt
Cyasterone 97%
Ambeed
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 8
od 153,44
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,4S,5R)-4-[(2R,3R)-2,3-dihydroxy-3-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]-3,5-dimethyloxolan-2-one (CAS 17086-76-9) to związek chemiczny o wzorze sumarycznym C29H44O8 i masie molowej 520.7 g/mol. Nazwa systematyczna IUPAC: (3S,4S,5R)-4-[(2R,3R)-2,3-dihydroxy-3-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]-3,5-dimethyloxolan-2-one. InChIKey: NEFYSBQJYCICOG-YSEUJXISSA-N.

Dane identyfikacyjne
Wzór sumarycznyC29H44O8
Masa molowa520.7 g/mol
Nazwa IUPAC(3S,4S,5R)-4-[(2R,3R)-2,3-dihydroxy-3-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]-3,5-dimethyloxolan-2-one
InChIKeyNEFYSBQJYCICOG-YSEUJXISSA-N
SMILESC[C@H]1[C@@H]([C@H](OC1=O)C)C[C@H]([C@@](C)([C@H]2CC[C@@]3([C@@]2(CC[C@H]4C3=CC(=O)[C@H]5[C@@]4(C[C@@H]([C@@H](C5)O)O)C)C)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Cyasterone, Cyasteron, cyasteron; Cyasterone;, Cyasterone CRS, Cyasterone (Standard), orb1222617, NEFYSBQJYCICOG-YSEUJXISSA-N
Powiązane formy tego związku
(3R,4S,5S)-4-[(2R,3R)-2,3-dihydroxy-3-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]-3,5-dimethyloxolan-2-one C29H44O8
(3R,4S,5R)-4-[(2R,3S)-2,3-dihydroxy-3-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]-3,5-dimethyloxolan-2-one C29H44O8
Izomery (ten sam wzór sumaryczny)
3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C29H44O8
(1R,2S,5S,10S,11R,12E,14S,15S,16S,17S,18R)-1,17-dihydroxy-10,11,18-trimethoxy-2,14,16-trimethyl-5-phenyl-4,19-dioxabicyclo[13.3.1]nonadec-12-en-3-one C29H44O8
(2,5-diacetyloxy-10-hydroxy-8,12,15,15-tetramethyl-4-methylidene-14-tricyclo[9.3.1.03,8]pentadec-11-enyl) 3-hydroxy-2-methylbutanoate C29H44O8
(3S,4S,6R)-4-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-1-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl]-3-methyloxan-2-one C29H44O8
3-[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C29H44O8
3-[(3S,5R,8R,9S,10S,13R,17R)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C29H44O8